Skip to content
Research Article Open access CC BY 4.0

From Pain Relief to Cancer Defense: The Promise of NSAIDs

Senthilnathan V., Priyadharshini V., Jenifer Selin Asha J.

Journal of Advances in Medical and Pharmaceutical Sciences · pp. 59–67 · Published 12 Oct 2023

10.9734/jamps/2023/v25i9643

Abstract

NSAIDs (Non-Steroidal Anti-inflammatory Drugs) are commonly used to treat various types of pain and inflammation. In recent decades, extensive scientific research has been conducted to examine the use of NSAIDs in the treatment and prevention of cancer. Chronic inflammation has been linked to various cancer types, suggesting that prolonged inflammation can promote genetic mutations and accelerate their accumulation within cells. The COX pathway, short for Cyclooxygenase pathway, is a critical biochemical pathway in the human body involved in the production of important signaling molecules called prostaglandins. Key factors like COX enzymes and cytokines are important in the development and progression of inflammation-induced cancer. Angiogenesis occurs during inflammation, and it plays a major role in cancer development and metastasis. NSAIDs inhibit this process, which may also contribute to their anticancer effects. This review highlights the potential of NSAIDs, particularly aspirin, ibuprofen, and celecoxib, to influence various aspects of tumor behavior. Although promising, further rigorous studies are needed to establish their clinical efficacy and safety in diverse cancer scenarios. The use of NSAIDs as adjunctive therapies along with conventional treatments presents a promising avenue for enhancing cancer management strategies.

NSAIDs inflammation angiogenesis tumor cancer treatment

References (40)

  1. 1 The Hallmarks of Cancer [DOI]
  2. 2 ROS signalling in the biology of cancer [DOI]
  3. 3 HIF-1α pathway: role, regulation and intervention for cancer therapy [DOI]
  4. 4 ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESIS [DOI]
  5. 5 Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth [DOI]
  6. 6 Cyclooxygenase-2 (COX-2)–Independent Anticarcinogenic Effects of Selective COX-2 Inhibitors [DOI]
  7. 7 Estimates of benefits and harms of prophylactic use of aspirin in the general population [DOI]
  8. 8 Molecular mechanisms of endothelial hyperpermeability: implications in inflammation [DOI]
  9. 9 Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene [DOI]
  10. 10 Vascular permeability—the essentials [DOI]
  11. 11 Macrophages, Inflammation, and Lung Cancer [DOI]
  12. 12 Platelets and cancer metastasis: A causal relationship? [DOI]
  13. 13 Blood cells and endothelial barrier function [DOI]
  14. 14 Mechanism of action of antiinflammatory drugs.
  15. 15 Tolfenamic Acid and Pancreatic Cancer Growth, Angiogenesis, and Sp Protein Degradation [DOI]
  16. 16 Celecoxib in Cancer Therapy and Prevention – Review [DOI]
  17. 17 Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation [DOI]
  18. 18 The epidemiology of Helicobacter pylori infection in Europe and the impact of lifestyle on its natural evolution toward stomach cancer after infection: A systematic review [DOI]
  19. 19 Monocarboxylate Transporter MCT1 Promotes Tumor Metastasis Independently of Its Activity as a Lactate Transporter [DOI]
  20. 20 Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer [DOI]
  21. 21 Lymphatic Vessels, Inflammation, and Immunity in Skin Cancer [DOI]
  22. 22 Advances in antitumor effects of NSAIDs [DOI]
  23. 23 Tumor-derived exosomes educate dendritic cells to promote tumor metastasis via HSP72/HSP105-TLR2/TLR4 pathway [DOI]
  24. 24 Unraveling the molecular mechanisms between inflammation and tumor angiogenesis.
  25. 25 Cyclooxygenase‐2 inhibition inhibits PI3K/AKT kinase activity in epithelial ovarian cancer [DOI]
  26. 26 Cancer may be a pathway to cell survival under persistent hypoxia and elevated ROS: A model for solid‐cancer initiation and early development [DOI]
  27. 27 Advances in research on the interaction between inflammation and cancer [DOI]
  28. 28 The effects of acetylsalicylic acid on proliferation, apoptosis, and invasion of cyclooxygenase‐2 negative colon cancer cells [DOI]
  29. 29 Ibuprofen Inhibits Colitis-Induced Overexpression of TumorRelated Rac1b [DOI]
  30. 30 A Role for Aspirin in Cancer Prevention? [DOI]
  31. 31 The Involvement of Endoplasmic Reticulum Stress in the Suppression of Colorectal Tumorigenesis by Tolfenamic Acid [DOI]
  32. 32 Introduction: T Cell Trafficking in Inflammation and Immunity [DOI]
  33. 33 Mast Cell Activation and KSHV Infection in Kaposi Sarcoma [DOI]
  34. 34 ANTI-METASTATIC EFFECT OF ASPIRIN [DOI]
  35. 35 Non-steroidal Anti-inflammatory Drugs (NSAIDS): Chemistry, Mechanism and their Adverse events. [DOI]
  36. 36 Features of management of patientswith NSAID-induced gastropathy: from understanding the mechanisms of development to the strategy of prevention and treatment. Risks of short-term use of non-steroidal anti-inflammatory drugs. Part I [DOI]
  37. 37 Suppressing growth and invasion of human hepatocellular carcinoma cells by celecoxib through inhibition of cyclooxygenase-2
  38. 38 Decreased activity of matrix metalloproteinases in gastric cancer stem cells by treatment with ibuprofen
  39. 39 The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1β [DOI]
  40. 40 Vascular Hyperpermeability, Angiogenesis, and Stroma Generation [DOI]

Cited by 6

Acetylsalicylic acid and cancer: updates on the new potential of a nature-inspired drug

Abdur Rauf, Ahmed Olatunde, Md. Rezaul Islam · Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

Advances in the Pathophysiology and Management of Cancer Pain: A Scoping Review

Giustino Varrassi, Antonella Paladini, Y Van Tran · Cancers · 2026

Showing 2 of 6 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

35

Page views

0

PDF downloads

7

Outbound clicks

6

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.